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Summary
Objective: To identify risk factors for recurrent catheter related bloodstream infections (CR-
BSIs). The study was undertaken at the University of Utah Hospital and involved patients who had
a CR-BSI followed by catheter removal and reinsertion between January 1998 and February 2002.
Design: A retrospective chart review for the cohort study of catheters initially infected, which
were then followed to study risk factors for a subsequent infection. Both central line and
peripherally inserted central line catheters were included in the study. A recurrent CR-BSI was
defined as positive blood cultures after three negative cultures, coupled with positive catheter
tip culture or no other evident new source of infection.
Results: Twenty-five (34%) of 73 patients had a recurrent CR-BSI. The first CR-BSI occurred amean
of 20.4 days after catheter insertion whereas recurrence developed a mean of 12.1 days after
reinsertion (p = 0.392). Coagulase-negative staphylococci (60%) were the most common cause of
recurrent infection. The recurrence was more common among the patients who were given blood
product transfusion (hazard ratio (HR) 2.3; confidence interval (CI) 1.02—5.67, p = 0.049). In 20
(27%) patients, catheters were changed over a guidewire. The guidewire catheter exchange was
not found to be associated with an increased risk of recurrent infection ( p = 0.582).
Conclusion: Catheter replacement to a new site, instead of rewiring, was not shown to decrease
the risk for recurrent infection. The transfusion of blood products was associated with an
increased risk for recurrent infection.
# 2006 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights
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catheter related bloodstream infections (CR-BSIs) are the
most serious and frequently occurring complications of CVC
use, carrying a high morbidity and mortality, and increasing
the costs of medical treatment and length of hospitaliza-
tion.2 Central venous catheters are estimated to be present
in 50% of all ICU patients and 70% of BSIs occur in patients
with CVCs.3 Catheter related bloodstream infections repre-
sent the main cause of hospital-acquired bacteremia, with anPublished by Elsevier Ltd. All rights reserved.
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respiratory intensive care units.4 The catheters infected with
the greatest frequency are central venous catheters (1—
20%).5
There are recent published guidelines (IDSA and CDC
committee) on optimizing catheter use.6,7 However, as
these guidelines have also emphasized, the clinical pro-
cesses of CR-BSIs need to be detailed. Following this recom-
mendation we aimed to shed light on the development of
infection recurrence in catheter use. We studied risk fac-
tors of recurrence in a cohort of patients who had a primary
CR-BSI.
Materials and methods
Hospital setting and study population
The study was conducted at the University of Utah Hospital, a
500-bed teaching hospital located in Salt Lake City, Utah,
USA, with the approval of the Institutional Research Board.
All the patients who had a CR-BSI between January 1998 and
February 2002 were included in the study. Using chart review
we performed a retrospective cohort study of catheters
initially infected, which were followed to study risk factors
for a subsequent infection outcome. Data were extracted to a
structured electronic database.
Microbiologic criteria
CR-BSI was defined by the following criteria: (1) positive
blood cultures obtained from a peripheral vein and semi-
quantitative catheter tip cultures (yielding 15 colony
forming units) for the same organism; (2) positive blood
cultures drawn by catheter and venepuncture for the same
organism and no other obvious source of infection apart
from the central line; (3) positive blood cultures obtained
by direct venepuncture with clinical symptoms of infection
and no other apparent focus of infection apart from the
central line, with/without tenderness, erythema or puru-
lent discharge within 2 cm of the catheter exit site. The
blood culture positivity was defined as two positive blood
cultures for coagulase-negative staphylococci, and one
positive blood culture for other microorganisms. Recurrent
CR-BSI was defined as positive blood cultures following
three negative cultures, coupled with positive catheter
tip culture or no other new source of infection evident.
Patients with persistent CR-BSIs were not included in the
study.
The catheter types were multilumen CVC, Swan—Ganz
catheter, hemodialysis catheter, peripherally inserted CVC,Figure 1 The clinical proceHickman catheter, and implanted central venous port. No
antimicrobial-impregnated catheters were used in this study.
Catheter replacement was recorded as catheters reinserted
using either the guidewire exchange or new site replace-
ment.
Data collected included patient demographics, diagnosis,
date of the first catheter insertion, catheter types, date of
CR-BSI, date of catheter removal, date of catheter reinser-
tion, reinserted catheter types, date of recurrence, isolated
microorganisms, comorbidities, major catheter complica-
tions, use of total parenteral nutrition (TPN) products and
blood via these catheters.
Study design and statistical analysis
The study period was from the date of catheter insertion until
the date of recurrence of CR-BSI, or catheter removal, or
discharge in five patients who were sent home with their
catheters. The study process is shown in Figure 1.
Cox regression was used to model CR-BSI recurrence. The
starting time point was reinsertion and the ending time
point was recurrence, catheter removal, or discharge from
the hospital with the catheter in place. The risk factors
included in the model were gender, age, patient unit (ICU,
Burns Unit, or elsewhere in the hospital), multilumen
catheters, infusate (blood or TPN), and reinsertion site
(guidewire vs. different site). Mean comparisons for con-
tinuous variables were done using independent groups t
tests. Proportion comparisons for categorical variables
were done using Chi-square tests, although Fisher’s exact
test was used when data were sparse. Significance was set
at p < 0.05 using two-sided comparisons.
Results
Seventy-three patients with a CR-BSI from January 1998 to
February 2002 were included in the study. All the patients
had catheter removal and reinsertion after the first infec-
tion. Twenty-five (34%) of the patients had a recurrent CR-
BSI.
The mean age of patients in the recurrent CR-BSI group
was 46, and 52% were male, whereas in the non-recurrent
infection group the mean age was 48, and 63% were male
( p = 0.629 and p = 0.748, respectively). Most of the patients
were followed at the Burns Unit and ICU (Table 1). Coagulase-
negative staphylococci were the most common cause of CR-
BSI and recurrent CR-BSI (Table 2).
The first CR-BSI occurred a mean of 19.3 days (standard
deviation (SD) 42.5 days) after catheter insertion for the
recurrent CR-BSI patients, and with a mean of 20.3 daysss for recurrent infection.
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Table 1 Characteristics of the patients and unadjusted analysis of risk factors for infection recurrence
Recurrent
CR-BSI n = 25 (%)
Non-recurrent
CR-BSI n = 48 (%)
Unadjusted
p value from Cox
regression
Gender
Male 13 (52) 30 (63) 0.748
Female 12 (48) 18 (37)
Wards (vs. other)
ICU 12 (48) 22 (46) 0.459
Burns unit 10 (40) 9 (19) 0.231
Reinsertion method
Rewire 8 (32) 12 (25) 0.582
New site 17 (68) 36 (75)
Blood administered
Yes 17 (68) 30 (63) 0.049
No 8 (32) 18 (37)
TPN administered
Yes 8 (32) 26 (54) 0.669
No 17 (68) 22 (46)
Diagnosis (present vs. absent)
Burn 10 (40) 9 (19) 0.039
Malignancy 1 (4) 4 (8) 0.654
Transplant 0 5 (10)
Renal disease 0 3 (6)
Cerebral bleeding 1 (4) 5 (10) 0.657
Trauma 2 (8) 6 (13) 0.707
Other 11 (44) 16 (33) 0.370
Reinserted catheter
Multilumen 20 (80) 26 (54) 0.131
Other (hemodialysis, picc, Hickman,
Swan—Ganz, cvport)
5 (20) 22 (46)
Picc: peripherally inserted central venous catheter; cvport: implanted central venous port.(SD 49 days) for the non-recurrent CR-BSI patients. The
recurrent infection developed a mean of 12.1 days (SD
10.4 days) after the reinsertion. This period was shorter than
for the first infection (not significant). The mean removal
time after first catheter infection was 39 hours (min 0, max
168 hours). The association between removal time and recur-Table 2 Isolated microorganisms
Recurrent CR-BSI n
Gram-positive
Coagulase-negative staphylococci 15 (60%)
Staphylococcus aureus 6 (24%)
Enterococcus spp. 2 (8%)
Gram-negative
Enterobacter species 0
Pseudomonas aeruginosa 1 (4%)
Klebsiella pneumoniae 0
Serratia marcescens 1 (4%)
Candida species 0
Total 25 (100%)rence was not significant. The mean time from removing the
first catheter to inserting the second was 7 hours (min 0, max
109 hours), and its association with recurrence was not sig-
nificant. The mean follow-up time for the non-recurrent CR-
BSI group was 27.5  19.3 days with a range of 11—106 days
after the initial CR-BSI.= 25 Non-recurrent CR-BSI n = 48 p Value
15 (31.3%) 0.018
17 (35.4%) 0.319
6 (12.5%) 0.707
2 (4.2%)
4 (8.3%) 0.654
1 (2.1%)
0
3 (6.3%)
48 (100%)
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Figure 2 Kaplan—Meier survival estimates by blood transfu-
sion, time from reinsertion to recurrence.Thirty-two percent of patients with a recurrent CR-BSI
received TPN, while 54% of patients without a recurrent CR-
BSI received TPN (Table 1). In the recurrent CR-BSI group 17
(68%) patients received blood products, compared to 30
(63%) patients in the non-recurrent group (Table 1).
In 20 (27%) patients, catheters were changed over a
guidewire. The guidewire catheter exchange was not found
to be associated with an increased risk of recurrent infection
(Table 1).
The percentages of patients in ICU were 48% and 46% in
recurrent and non-recurrent infection groups, respectively.
Comorbidity (malignancy, chronic renal failure, diabetes
mellitus, HIV, immunosuppression) was present in 16 (33%)
patients in the non-recurrent group and six (24%) patients in
the recurrent group. All of the patients were given antibiotics
following their first CR-BSI.
In a multivariable Cox regression model, infusion of blood
products was found to be a significant risk factor for recurrent
infection (hazard ratio (HR) 2.3; confidence interval (CI)
1.02—5.67, p = 0.049) (Figure 2).
Discussion
We limited our study to recurrent infections. In this study, the
most commonly used intravenous devices were multilumen
CVCs and recurrence was common with their use. Multilumen
CVCs are used extensively for the administration of fluids and
electrolytes, blood products, drugs, and nutritional support.
Central venous access is necessary for chemotherapy for
malignant diseases or serious infectious diseases and for
TPN. In addition, in intensive care units these devices are
used for continuous hemodynamic monitoring in critically ill
patients.8 More than 15% of patients who receive these
catheters have complications. Mechanical complications
are reported to occur in 5—19% of patients, infectious com-
plications in 5—26%, and thrombotic complications in 2—
26%.9
Types of organisms that most commonly cause CR-BSIs
change over time. Staphylococci are the most frequently
isolated pathogens in CR-BSI, particularly coagulase-negative
staphylococci, followed by enterococci.6,10—14 In this study,
the organisms isolated were consistent with the results ofother studies, and coagulase-negative staphylococci (41%)
were found to be the most common cause of CR-BSI, followed
by Staphylococcus aureus (32%), enterococci (11%), and
Pseudomonas aeruginosa (7%). It has been reported that
coagulase-negative staphylococcal CR-BSI may resolve with
removal of the catheter and no antibiotic therapy, yet many
experts believe that such infections should be treated with
antibiotics.6 In this study, although all of the catheters were
removed, recurrence was seen more frequently in patients
who had a CR-BSI due to coagulase-negative staphylococci.
Molecular typing for coagulase-negative staphylococci was
not performed. This is one of the limitations of the study.
Burned skin always becomes colonized by multiple bac-
teria and these patients are at high risk of acquiring a CR-BSI.
P. aeruginosa is the most frequently isolated microorganism
from catheters in burned patients.8 In this study, in burned
patients, 37% of isolated microorganisms were coagulase-
negative staphylococci, whereas 10.5% were P. aeruginosa,
and recurrence was found to be highest in burns patients.
In our univariate analysis (Table 1) we present the burns
patients in two separate groups — in ‘wards’ and ‘diagnosis’.
On the other hand in multivariate analysis, to avoid colli-
nearity, only the wards were included in the regression
model. In univariate analysis, the recurrent infections in
the burns unit were not significantly high compared to ICU
and other wards, whereas the recurrent infections were
found to be significantly high among burned patients com-
pared to those with other diagnoses.
The patients who were given blood product transfusion
were associated with an increased risk of recurrent infection
(HR 2.3; CI 1.02—5.67, p = 0.049). Shah et al. reported that
patients with CR-BSIs needed blood product transfusions
more often than controls. It is possible that requirement
for blood product transfusion was a marker for prolonged
bone marrow suppression and not causally related to CVC-
associated BSIs.15
When a CR-BSI is suspected many clinicians prefer to
replace the catheter by guidewire exchange. Although the
guidewire technique is commonly used, little scientific evi-
dence supports its use if a catheter-associated infection is
suspected. It has been reported that guidewire exchange
appears to be associated with a greater risk of catheter
colonization and CR-BSI, but fewer mechanical complications
than new site replacement.2,3,16 A review analyzing 12 rele-
vant randomized trials of catheter replacement over a guide-
wire or at a new site, did not demonstrate that guidewire
exchange, as compared with new-site replacement, was
associated with a greater increase in colonization or cathe-
ter-related bacteremia in patients with suspected infection
than in patients without suspected infection.17 In an experi-
mental study it was reported that removal of a colonized
catheter and replacement using a guidewire was associated
with rapid colonization of the new catheter.18 Replacement
of temporary catheters over a guidewire in the presence of
bacteremia is not believed to be an acceptable replacement
strategy, because the source of infection is usually coloniza-
tion of the skin tract from the insertion site to the vein.
However, in selected patients with tunneled hemodialysis
catheters and bacteremia, catheter exchange over a guide-
wire, in combination with antibiotic therapy, might be an
alternative as a salvage strategy in patients with limited
venous access.7 In our study, the catheters changed over a
400 A. Erbay et al.guidewire and guidewire catheter exchange were not found
to be associated with an increased risk of recurrence com-
pared to reinsertion to a new site.
The safe time for reinsertion of a new catheter after
removal of a colonized catheter from a patient with a CR-
BSI still remains obscure. There are currently no adequate
data regarding this issue.10 We examined the removal and
reinsertion times of the catheters in the patients with a CR-
BSI in this study. As CVCs were essential for the clinical
management of many patients, after removal, catheters
were usually reinserted on the same day, and no statistically
significant association was observed between reinsertion
time and recurrence. However, our study lacks sufficient
data on extended gaps between removal and reinsertion to
adequately study this question.
It was observed that development of a recurrent infection
took a shorter time compared to the time taken to first CR-
BSI. The first CR-BSI occurred a mean of 20.4 days after
catheter insertion whereas recurrence developed a mean
of 12.1 days following reinsertion, although this is not sta-
tistically significant ( p = 0.392).
In conclusion, catheter replacement to a new site, instead
of rewiring, was not shown to decrease the risk for recurrent
infection. The transfusion of blood products was associated
with an increased risk for recurrent infection.
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